QUESTLAB Stock Overview
Manufactures and markets pharmaceutical formulations in India.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 5/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Quest Laboratories Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₹158.65 |
52 Week High | ₹196.80 |
52 Week Low | ₹102.00 |
Beta | 0 |
11 Month Change | n/a |
3 Month Change | n/a |
1 Year Change | n/a |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 7.67% |
Recent News & Updates
Recent updates
Shareholder Returns
QUESTLAB | IN Pharmaceuticals | IN Market | |
---|---|---|---|
7D | 14.3% | -1.1% | 0.9% |
1Y | n/a | 51.1% | 45.3% |
Return vs Industry: Insufficient data to determine how QUESTLAB performed against the Indian Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how QUESTLAB performed against the Indian Market.
Price Volatility
QUESTLAB volatility | |
---|---|
QUESTLAB Average Weekly Movement | n/a |
Pharmaceuticals Industry Average Movement | 6.0% |
Market Average Movement | 6.5% |
10% most volatile stocks in IN Market | 9.5% |
10% least volatile stocks in IN Market | 4.3% |
Stable Share Price: QUESTLAB's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine QUESTLAB's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1994 | 84 | Anil Sabarwal | questlabltd.com |
Quest Laboratories Limited manufactures and markets pharmaceutical formulations in India. It offers ethical drugs, generic drugs, and over the-counter drugs under various categories, such as antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and others. The company offers its products in various forms, such as tablets, liquid orals, oral dry powders, oral powders, ointments, and external liquids.
Quest Laboratories Limited Fundamentals Summary
QUESTLAB fundamental statistics | |
---|---|
Market cap | ₹2.60b |
Earnings (TTM) | ₹100.94m |
Revenue (TTM) | ₹825.63m |
25.8x
P/E Ratio3.1x
P/S RatioIs QUESTLAB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
QUESTLAB income statement (TTM) | |
---|---|
Revenue | ₹825.63m |
Cost of Revenue | ₹522.45m |
Gross Profit | ₹303.18m |
Other Expenses | ₹202.24m |
Earnings | ₹100.94m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 6.16 |
Gross Margin | 36.72% |
Net Profit Margin | 12.23% |
Debt/Equity Ratio | 17.7% |
How did QUESTLAB perform over the long term?
See historical performance and comparison